article thumbnail

Intoxicating Hemp Swindle

Project CBD

For some perspective on the matter, Project CBD turned to Marc Scialdone, a molecular chemist with Saint Michaels College in Vermont, who co-authored a 2023 paper for the International Cannabinoid Research Society ( ICRS ) entitled The Dark Side of Cannabidiol. “The market crashed. Devitt expresses serious safety concerns.

Hemp 233
article thumbnail

Australia Cannabis Q&A

Canna Law Blog

The Office of Drug Control (ODC) issues several license types, including: Cultivation growing cannabis for medicinal or research purposes. Research studying cannabis for medicinal development. Businesses should also investigate potential research and development (R&D) incentives if applicable.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Increase Cannabis Yield with Proven Techniques

Medicinal Genomics

Research shows some cannabis varieties can sustain their quality while increasing yield through 1800 mol, which is double what many growers are using as a peak intensity value. For optimal plant development, growers should adjust their irrigation strategies based on crop steering principles. More light isnt always better. Early Flower.

article thumbnail

CBD vs. THC: Medical Benefits and Key Differences

Miss Marijuana

Keep up to date with reliable sources, like NORML , to stay informed about the latest developments. While more research is needed, many people have found relief using CBD products. Research on CBD’s anxiolytic (anti-anxiety) properties has shown that it might help calm the mind and reduce feelings of stress.

THC 52
article thumbnail

Natural Alternatives to Prescription Pain Medications in 2025

Miss Marijuana

Research shows that nearly 50 million adults experience chronic pain, driving a growing interest in holistic treatment approaches that address root causes and promote healing. Willow Bark : Willow bark has long been used as a natural painkiller, and it’s often referred to as “nature’s aspirin.”

article thumbnail

Cannabinoids for Scleroderma

Project CBD

Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials. Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2.

article thumbnail

Australian Scientists Say They Have “developed the world’s most complete medicinal cannabis genomic reference.”

Cannabis Law Report

Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].